

Fundamental dimension Equity attribute | ELOXPeer $12.80▼-2.44% Cap $43.98MP/E -8.4x QuantScore36/100 | BIOCQLeader $0.00030.00% Cap $788P/E -0.0x QuantScore52/100 | CDXIPeer $0.00010.00% Cap $80P/E -0.0x QuantScore37/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
26/100 |
94/100 |
65/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 50/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 43/100 | 44/100 | 23/100 |
Growth Revenue / earnings growth & margins | 0/100 | 20/100 | 26/100 |
Sentiment Analyst ratings, targets & revisions | 75/100 | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -8.4x | -0.0x | -0.0x |
Forward P/E (next FY) | -5.7x | -0.0x | — |
EV / EBITDA (TTM) | 2.2x | 0.0x | -1.8x |
Price / Sales | — | 0.0x | 0.0x |
Price / Free Cash Flow | -4.3x | -0.0x | -0.0x |
PEG ratio | -0.10 | 0.00 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | — | 3 / 9 |
Altman Z-Score | -4.96 (Distress) | — | -91.48 (Distress) |
Total debt / equity | 0.00 | 1.37 | -0.47 |
Quick ratio | 3.7x | 2.8x | 0.0x |
Interest coverage | -222.8x | -101.2x | -1.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -100.0% | -57.8% | -24.2% |
Net income growth YoY | -90.7% | -1036.2% | +0.7% |
Gross margin (TTM) | 0.0% | -10.0% | 63.6% |
Operating margin (FY) | — | -123.7% | -568.3% |
FCF margin (FY) | — | -54.5% | -335.1% |
5. Trailing price performancePrice change over period |
1M return | -20.0% | +50.0% | +0.0% |
3M return | +7.2% | +200.0% | +0.0% |
6M return | +16.3% | +200.0% | +0.0% |
Year to date | +16.3% | +200.0% | +0.0% |
1Y return | +16.3% | +200.0% | +0.0% |
3Y return | +16.3% | -99.9% | -50.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $1.22 -90.4% premium | $-7,141.70 -2380567319.0% premium | $-9.67 -9674404.4% premium |
Wall Street consensus target | $37.67 +194.3% · range $32.00–$43.00 | — — | — — |
Consensus stance | 75% Buy25% Hold0% Sell | — | — |